No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Adjuvants, Immunologic*
-
Adjuvants, Pharmaceutic
-
Humans
-
Neoplasm, Residual
-
Nivolumab* / adverse effects
Substances
-
Adjuvants, Immunologic
-
Adjuvants, Pharmaceutic
-
Nivolumab